Elmer 2017 US Patent

From Bioblast
Jump to: navigation, search
Publications in the MiPMap
Elmer E, Hansson MJ, Ehinger JK, Piel S, Moss S (2017) Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to complex I-related impairment of mitochondrial oxidative phosphorylation. US Patent US20170100359 A1.

» Open Access

Elmer E, Hansson MJ, Ehinger JK, Piel S, Moss S (2017) US Patent

Abstract: The present invention relates to a succinate prodrug for use in the treatment or prevention of lactic acidosis.


Bioblast editor: Kandolf G O2k-Network Lab: SE Lund Elmer E


Labels: MiParea: Respiration, Pharmacology;toxicology 


Organism: Human  Tissue;cell: Heart, Blood cells, Fibroblast, Macrophage-derived, Platelet  Preparation: Intact cells 


Coupling state: LEAK, ROUTINE, OXPHOS, ET  Pathway: S, ROX  HRR: Oxygraph-2k 

Labels, PBMCs